PAQ Therapeutics secures $39 million in Series B financing to advance its KRAS degrader PT0253, co-led by MRL Ventures Fund and Bayland Capital.
Amount Raised
$39 Million
Round Type
Series B
BurlingtonBiotechnologyHealth CareTherapeuticsInvestors
Description
PAQ Therapeutics, a biotechnology firm, announced its completion of a $39 million Series B funding round. The financing is aimed at advancing their lead asset PT0253 into further clinical development, following the dosing of the first patient in a Phase 1 trial. The round was co-led by MRL Ventures Fund and Bayland Capital, with investments from several notable firms. These funds will also support further development of PAQ's additional assets.
Quick answer
PAQ Therapeutics raised $39 Million in a Series B round, dated May 7, 2025. Investors: Lav Fund, MRL Ventures Fund, Bayland Capital, BioTrack Capital, Sherpa Health Partners and Johnson & Johnson Innovation – Jjdc, Inc. PAQ Therapeutics is based in Burlington, Massachusetts, United States.
- How much did PAQ Therapeutics raise?
- PAQ Therapeutics raised $39 Million in a Series B round on May 7, 2025.
- Who invested in PAQ Therapeutics?
- Lav Fund, MRL Ventures Fund, Bayland Capital, BioTrack Capital, Sherpa Health Partners and Johnson & Johnson Innovation – Jjdc, Inc. are named as investors in this round.
- What does PAQ Therapeutics do?
- PAQ Therapeutics is a biotechnology company pioneering a new approach to restoring heath and curing disease through autophagy, the body’s most versatile mechanism for natural cellular degradation.
- Where is PAQ Therapeutics based and how big is it?
- PAQ Therapeutics is based in Burlington, Massachusetts, United States. Fundz records about 8 employees.
- Who are the decision-makers at PAQ Therapeutics?
- Fundz holds 1 contact at PAQ Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as PAQ Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Actio Biosciences raised $66M (Series B) on June 18, 2025.
- Canton Strategic Holdings, Inc. raised $2.5M (Seed) on June 13, 2025.
- Arialys Therapeutics raised $15M on June 13, 2025.
- ADC Therapeutics raised $100M (Private Equity) on June 12, 2025.
- Ensho Therapeutics raised $23M on June 12, 2025.
- Elkedonia raised $13M (Seed) on June 11, 2025.
Who to call at PAQ Therapeutics, and when
A new round usually means PAQ Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day PAQ Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at PAQ Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at PAQ Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment PAQ Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansPAQ Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.